Effect of Music on Pain and Anxiety in Palliative Cancer Patients

November 22, 2025 updated by: Gülsüm Kehribar, Karamanoğlu Mehmetbey University

The Determination of the Effect of Music on Pain, Anxiety, and Vital Findings in Cancer Patients Treated in Palliative Care Centers : a Quasi-experimental Study

Background: Cancer patients receiving palliative care often endure a variety of distressing symptoms, most notably pain and anxiety. Evidence suggests that music offers a symptom-alleviating effect for these patients and can also influence their physiological parameters.

Aim: This investigation was structured as a quasi-experimental study utilizing a pre-test and post-test design with a control group. Its goal was to ascertain the influence of music on pain levels, anxiety states, and vital signs among cancer patients admitted to a palliative care facility.

Methods: Data collection relied on the Patient Demographic Form, the Visual Analog Scale (VAS), the State-Trait Anxiety Inventory (STAI), and a Physiological Parameter Monitoring Form. The intervention group was exposed to relaxing instrumental Turkish music in the maqams of Hicaz and Buselik for a single 30-minute session using MP3 players and headphones, whereas the control group was instructed to observe 30 minutes of bed rest without any other activity. Measurements were taken at baseline (pre-intervention) and immediately after the 30-minute intervention period between 10:00 AM and 5:00 PM following the patient's morning analgesic dose.

Study Overview

Detailed Description

Advances in medicine have increased life expectancy, leading to a rise in chronic diseases like cancer, with 14 million new cases annually, projected to reach 22 million by 2030. Cancer patients often face intensive treatments and severe symptoms, including pain and anxiety, highlighting the need for palliative care.

Nurses play a key role in symptom management, using both pharmacological and non-pharmacological methods, including music therapy. Music can stimulate neuroendocrine responses by increasing dopamine and serotonin release, activating the limbic system, increasing endorphin release, and suppressing sympathetic nervous system activity, which contributes significantly to reducing pain and anxiety while also affecting the regulation of vital signs such as blood pressure, pulse, body temperature, respiratory rate, and oxygen saturation.

This study examined the effects of music on pain, anxiety, and vital signs in 32 palliative care cancer patients using a quasi-experimental design with a pretest-posttest control group. The study was conducted between February 2021 and June 2022 at Yozgat City Hospital Palliative Care Center and Karaman Training and Research Hospital Palliative Care Center.

Patients in the intervention group listened to 30 minutes of instrumental Turkish music in the maqams of Hicaz and Buselik; controls rested quietly. The music CD was prepared by experts from the Applied Music Therapy Association (UMTED) and consisted of 13 instrumental works designed to provide relaxation and have a sedative effect. The volume was kept low and the main melody was emphasized.

Data collection took approximately 60 minutes per participant. The intervention was performed between 10:00 AM and 5:00 PM after patients received their first daily analgesic dose. Headphones were used to maintain focus and block extraneous noise, with separate devices for each patient to ensure infection control standards. Further research should explore mechanisms, patient differences, and optimal implementation protocols.

Study Type

Interventional

Enrollment (Actual)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Merkez
      • Yozgat, Merkez, Turkey (Türkiye), 66000
        • Yozgat city hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Eligibility Criteria:

Inclusion Criteria:

  • Diagnosed with cancer
  • Receiving palliative care treatment at Yozgat City Hospital or Karaman Training and Research Hospital
  • Hospitalized in the palliative care center for at least 7 days
  • Aged 18 years or older
  • Able to speak and understand Turkish
  • Able to communicate verbally
  • Oriented to place and time
  • No psychiatric disease
  • No vision or hearing problems
  • Self-reported pain intensity of at least 3 on the Visual Analog Scale in the last 24 hours
  • Voluntarily agreed to participate in the study
  • Provided written informed consent

Exclusion Criteria:

  • Underwent major surgical intervention within the last month
  • Currently using another complementary and integrative treatment (e.g., aromatherapy, acupuncture)
  • Cognitive impairment preventing questionnaire completion
  • Not open to communication
  • Died within seven days of hospital admission

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Music Intervention Group

Before the single-session intervention, the researcher administered the Patient Description Form, STAI, and VAS, and recorded baseline vital signs (Blood Pressure, Pulse Rate, Respiratory Rate, Body Temperature, SpO2).

The intervention was scheduled between 10:00 a.m. and 5:00 p.m. following the patient's morning analgesic dose. Participants rested comfortably for 30 minutes while listening to music using an MP3 player and headphones. Headphones were used to enhance focus and minimize external noise, with separate devices used for each patient to adhere to infection control standards. Immediately post-intervention (second follow-up), VAS, State Anxiety Inventory, and vital signs were re-measured and recorded.

Before the single-session intervention, the researcher administered the Patient Description Form, STAI, and VAS, and recorded baseline vital signs (Blood Pressure, Pulse Rate, Respiratory Rate, Body Temperature, SpO2).

The intervention was scheduled between 10:00 a.m. and 5:00 p.m. following the patient's morning analgesic dose. Participants rested comfortably for 30 minutes while listening to music using an MP3 player and headphones. Headphones were used to enhance focus and minimize external noise, with separate devices used for each patient to adhere to infection control standards. Immediately post-intervention (second follow-up), VAS, State Anxiety Inventory, and vital signs were re-measured and recorded.

Other: Control Group
Procedures for the Control Group
The control group followed the same two-phase data collection protocol as the intervention group (first follow-up). After baseline data collection, the control group was instructed to rest quietly in bed for 30 minutes without any other activity. Immediately after the rest period (second follow-up), the VAS, State Anxiety Inventory, and vital signs were measured and recorded.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
• Visual Analog Scale
Time Frame: Baseline (Pre-Intervention) and Immediately Post-Intervention (Total 30-minute intervention period).
A standard 10 cm tool (Price et al., 1983) where patients mark their current pain level (0 = no pain, 10 = worst possible pain).
Baseline (Pre-Intervention) and Immediately Post-Intervention (Total 30-minute intervention period).

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
State Anxiety (State-Trait Anxiety Inventory - State Subscale)
Time Frame: Baseline (Pre-Intervention) and Immediately After Intervention (30-minute intervention period).
Developed by Spielberger et al. (1970) and validated for Turkish by Öner and Le Compte (1985). This inventory measures transient (State) anxiety; higher scores indicate higher anxiety. Scores range from 20 to 80. Internal consistency (Cronbach's alpha) in this study was 0.81 for State Anxiety.
Baseline (Pre-Intervention) and Immediately After Intervention (30-minute intervention period).
Trait Anxiety (State-Trait Anxiety Inventory - Trait Subscale)
Time Frame: Baseline (Pre-Intervention) only.
Developed by Spielberger et al. (1970) and validated for Turkish by Öner and Le Compte (1985). This inventory measures general (Trait) anxiety; higher scores indicate higher anxiety. Scores range from 20 to 80. Internal consistency (Cronbach's alpha) in this study was 0.76 for Trait Anxiety.
Baseline (Pre-Intervention) only.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Systolic Blood Pressure (mmHg)
Time Frame: Baseline (Pre-Intervention) and Immediately Post-Intervention (30-minute intervention period).
Measured using standardized sphygmomanometer according to clinical standards at baseline and immediately post-intervention.
Baseline (Pre-Intervention) and Immediately Post-Intervention (30-minute intervention period).
Diastolic Blood Pressure (mmHg)
Time Frame: Baseline (Pre-Intervention) and Immediately Post-Intervention (30-minute intervention period).
Measured using standardized sphygmomanometer according to clinical standards at baseline and immediately post-intervention.
Baseline (Pre-Intervention) and Immediately Post-Intervention (30-minute intervention period).
Heart Rate (beats per minute)
Time Frame: Baseline (Pre-Intervention) and Immediately Post-Intervention (30-minute intervention period).
Measured using standardized pulse oximeter at baseline and immediately post-intervention.
Baseline (Pre-Intervention) and Immediately Post-Intervention (30-minute intervention period).
Respiratory Rate (breaths per minute)
Time Frame: Baseline (Pre-Intervention) and Immediately Post-Intervention (30-minute intervention period)
Measured by observation according to clinical standards at baseline and immediately post-intervention.
Baseline (Pre-Intervention) and Immediately Post-Intervention (30-minute intervention period)
Body Temperature (degrees Celsius)
Time Frame: Baseline (Pre-Intervention) and Immediately Post-Intervention (30-minute intervention period).
Measured using a digital thermometer at baseline and immediately post-intervention.
Baseline (Pre-Intervention) and Immediately Post-Intervention (30-minute intervention period).
Oxygen Saturation (SpO₂) (%)
Time Frame: Baseline (Pre-Intervention) and Immediately Post-Intervention (30-minute intervention period).
Measured using standardized pulse oximeter at baseline and immediately post-intervention.
Baseline (Pre-Intervention) and Immediately Post-Intervention (30-minute intervention period).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Pınar Tekinsoy Kartın, https://sbf.erciyes.edu.tr/

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2021

Primary Completion (Actual)

June 1, 2022

Study Completion (Actual)

June 1, 2022

Study Registration Dates

First Submitted

November 16, 2025

First Submitted That Met QC Criteria

November 22, 2025

First Posted (Estimated)

December 3, 2025

Study Record Updates

Last Update Posted (Estimated)

December 3, 2025

Last Update Submitted That Met QC Criteria

November 22, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer

Clinical Trials on Music Application

Subscribe